# Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied Four Times Daily in Subjects With Acute Ankle Sprain

> **NCT01272934** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 205 (actual)

## Conditions studied

- Acute Ankle Sprain

## Interventions

- **DRUG:** Diclofenac Sodium
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01272934
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 205 (ACTUAL)
- **Last updated:** 2013-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01272934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01272934, "Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied Four Times Daily in Subjects With Acute Ankle Sprain". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01272934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*